Canada - TSX Venture Exchange - TSX-V:MDX - CA5850901037 - Common Stock
The current stock price of MDX.CA is 0.05 CAD. In the past month the price decreased by -16.67%. In the past year, price decreased by -23.08%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRN.CA | PROFOUND MEDICAL CORP | N/A | 276.50M | ||
| MIR.CA | MEDMIRA INC | N/A | 53.08M | ||
| CNVI.CA | CONAVI MEDICAL CORP | N/A | 41.45M | ||
| TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 38.41M | ||
| PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 20.79M | ||
| ASG.CA | AURORA SPINE CORP | N/A | 20.85M | ||
| NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 20.09M | ||
| VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 15.09M | ||
| THRM.CA | THERMA BRIGHT INC | N/A | 2.84M | ||
| IVC-H.CA | INTERCONNECT VENTURES CORP | N/A | 1.07M | ||
| VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 439.40K | ||
| IDL.CA | IMAGING DYNAMICS CO LTD | N/A | 413.20K |
MedX Health Corp. engages in the development, manufacture, and sale of medical device and software. The company is headquartered in Mississauga, Ontario. The company went IPO on 2008-02-12. The company develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. The company focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
MEDX HEALTH CORP
1495 Bonhill Road, Unit # 1 Mississauga
Mississauga ONTARIO L5T 1M2 CA
CEO: Scott Spearn
Employees: 15
Phone: 18883633112
MedX Health Corp. engages in the development, manufacture, and sale of medical device and software. The company is headquartered in Mississauga, Ontario. The company went IPO on 2008-02-12. The company develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. The company focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
The current stock price of MDX.CA is 0.05 CAD.
MDX.CA does not pay a dividend.
MDX.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MDX.CA.
MEDX HEALTH CORP (MDX.CA) has a market capitalization of 15.44M CAD. This makes MDX.CA a Nano Cap stock.
Over the last trailing twelve months MDX.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -0.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -475.4% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |